Mexican pharmaceutical manufacturer Sanfer has invested more than $40 million to expand pharmaceutical production capacity in Colombia, targeting export markets across Latin America and the Caribbean, according to a Sanfer-supported …
Mexican pharmaceutical manufacturer Sanfer has invested more than $40 million to expand pharmaceutical production capacity in Colombia, targeting export markets across Latin America and the Caribbean, according to a Sanfer-supported …
Ecuador’s government is in talks with Colombia, India, Argentina, and Costa Rica to procure medicines for public hospitals, as shortages and a trade dispute with Colombia strain the health system.
Colombia’s highest administrative court suspended Decree 0182 on May 4, 2026, freezing a territorial restructuring of health insurers that would have forcibly reassigned an estimated 6.6 million affiliates.
Colombia’s Ministry of Health declared public interest grounds to pursue mandatory licensing of Gilead’s sofosbuvir-based hepatitis C patents, transferring the process to the competition authority for a final determination.
PASSUS IPS, a Colombian healthcare provider, has warned it may suspend services due to unpaid debts from EPS insurers, exposing a structural financing gap in Colombia’s health system.
You must be logged in to post a comment.